, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, World Health Organ Tech Rep Ser, vol.843, pp.1-129, 1994.

D. Bliuc, N. D. Nguyen, V. E. Milch, T. V. Nguyen, J. A. Eisman et al., Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women, JAMA, vol.301, pp.513-534, 2009.

F. Berenbaum, M. Rousière, and . Ostéoporose, , 2016.

C. Cooper and L. J. Melton, Epidemiology of osteoporosis, Trends Endocrinol Metab, vol.3, pp.224-233, 1992.

C. M. Klotzbuecher, P. D. Ross, P. B. Landsman, T. A. Abbott, and M. Berger, Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis, J Bone Miner Res, vol.15, pp.721-760, 2000.

R. Lindsay, S. L. Silverman, C. Cooper, D. A. Hanley, I. Barton et al., Risk of new vertebral fracture in the year following a fracture, JAMA, vol.285, pp.320-323, 2001.

T. A. Van-geel, . Cm, S. Van-helden, P. P. Geusens, B. Winkens et al., Clinical subsequent fractures cluster in time after first fractures, Ann Rheum Dis, vol.68, pp.99-102, 2009.

P. Dargent-molina, C. Benhamou, B. Cortet, B. Sutter, and T. Thomas, Devising global strategies for fracture-risk evaluation, Joint Bone Spine, vol.74, pp.240-244, 2007.

N. Legoupil, La densitométrie osseuse. Revue du Podologue, vol.65, pp.25-33, 2015.

J. A. Kanis, F. Borgstrom, D. Laet, C. Johansson, H. Johnell et al., Assessment of fracture risk, Osteoporos Int, vol.16, pp.581-590, 2005.

A. Bazzocchi, P. Spinnato, F. Fuzzi, D. Diano, A. M. Morselli-labate et al., Vertebral fracture assessment by new dual-energy X-ray absorptiometry, Bone, vol.50, pp.836-877, 2012.

M. S. Van-brussel and W. F. Lems, Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment, Curr Osteoporos Rep, vol.7, pp.103-109, 2009.

D. Diacinti, G. Guglielmi, D. Pisani, D. Diacinti, R. Argirò et al., Vertebral morphometry by dual-energy X-ray absorptiometry (DXA) for osteoporotic vertebral fractures assessment (VFA), Radiol Med, vol.117, pp.1374-85, 2012.

J. T. Schousboe and C. R. Debold, Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice, Osteoporos Int, vol.17, pp.281-290, 2006.

G. F. Jensen, P. Mcnair, J. Boesen, and V. Hegedüs, Validity in diagnosing osteoporosis. Observer variation in interpreting spinal radiographs, Eur J Radiol, vol.4, pp.1-3, 1984.

H. K. Genant, C. Y. Wu, C. Van-kuijk, and M. C. Nevitt, Vertebral fracture assessment using a semiquantitative technique, J Bone Miner Res, vol.8, pp.1137-1185, 1993.

C. Y. Wu, J. Li, M. Jergas, and H. K. Genant, Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures, Osteoporos Int, vol.5, pp.354-70, 1995.

R. Rizzoli, S. Boonen, M. Brandi, O. Bruyère, C. Cooper et al., Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Curr Med Res Opin, vol.29, pp.305-318, 2013.

S. Ferrari, J. D. Adachi, K. Lippuner, C. Zapalowski, P. D. Miller et al., Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years, Osteoporos Int, vol.26, pp.2763-71, 2015.

S. Papapoulos, K. Lippuner, C. Roux, C. Lin, D. L. Kendler et al., The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study, Osteoporos Int, vol.26, pp.2773-83, 2015.

D. M. Black, I. R. Reid, S. Boonen, C. Bucci-rechtweg, J. A. Cauley et al., The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT), J Bone Miner Res, vol.27, pp.243-54, 2012.

C. J. Crandall, S. J. Newberry, A. Diamant, Y. Lim, W. F. Gellad et al., Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review, Ann Intern Med, vol.161, pp.711-734, 2014.

F. Guillemin, A. Saraux, P. Guggenbuhl, C. H. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, vol.64, pp.1427-1457, 2001.

S. Allaire, F. Wolfe, J. Niu, and M. P. Lavalley, Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US, Arthritis Rheum, vol.59, pp.474-80, 2008.

T. Sokka, B. Abelson, and P. T. , Mortality in rheumatoid arthritis: 2008 update, Clin Exp Rheumatol, vol.26, issue.5, pp.35-61, 2008.

J. S. Smolen, R. Landewé, F. C. Breedveld, M. Dougados, P. Emery et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Ann Rheum Dis, vol.69, pp.964-75, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01778213

M. A. Stoffer, M. M. Schoels, J. S. Smolen, D. Aletaha, F. C. Breedveld et al., Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update, Ann Rheum Dis, vol.75, pp.16-22, 2016.

J. S. Smolen, F. C. Breedveld, G. R. Burmester, V. Bykerk, M. Dougados et al., Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force, Ann Rheum Dis, vol.75, pp.3-15, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01890959

A. Södergren, B. Stegmayr, V. Lundberg, M. Öhman, and S. Wållberg-jonsson, Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis, Ann Rheum Dis, vol.66, pp.263-269, 2007.

C. Turesson, A. Jarenros, and L. Jacobsson, Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study, Ann Rheum Dis, vol.63, pp.952-957, 2004.

P. J. Nicola, H. Maradit-kremers, V. L. Roger, S. J. Jacobsen, C. S. Crowson et al., The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years, Arthritis Rheum, vol.52, pp.412-432, 2005.

L. Lévy, B. Fautrel, T. Barnetche, and T. Schaeverbeke, Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature, Clin Exp Rheumatol, vol.26, pp.673-682, 2008.

S. Van-doornum, C. Brand, B. King, and V. Sundararajan, Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, pp.2061-2069, 2006.

M. Soubrier, N. Barber-chamoux, Z. Tatar, M. Couderc, J. Dubost et al., Risque cardiovasculaire de la polyarthrite rhumatoïde, Revue du rhumatisme, vol.4, pp.281-286, 2014.

C. Gaujoux-viala, L. Gossec, A. Cantagrel, M. Dougados, B. Fautrel et al., Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde, Revue du Rhumatisme, vol.81, pp.303-315, 2014.

M. Peters, D. Symmons, D. Mccarey, B. Dijkmans, .. C. Nicola et al., EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis, Ann Rheum Dis, vol.69, pp.325-356, 2010.

S. Cobb, F. Anderson, and W. Bauer, Length of life and cause of death in rheumatoid arthritis, N Engl J Med, vol.249, pp.553-559, 1953.

J. Franklin, M. Lunt, D. Bunn, D. Symmons, and A. Silman, Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis, Ann Rheum Dis, vol.66, pp.308-320, 2007.

W. G. Dixon, S. Suissa, and M. Hudson, The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses, Arthritis Res Ther, vol.13, p.139, 2011.

J. P. Leombruno, T. R. Einarson, and E. C. Keystone, The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events, Ann Rheum Dis, vol.68, pp.1136-1181, 2009.

A. E. Thompson, S. W. Rieder, and J. E. Pope, Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials, Arthritis Rheum, vol.63, pp.1479-85, 2011.

C. Salliot, M. Dougados, and L. Gossec, Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials, Ann Rheum Dis, vol.68, pp.25-32, 2009.

L. Campbell, C. Chen, S. S. Bhagat, R. A. Parker, and A. Östör, Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials, Rheumatology (Oxford), vol.50, pp.552-62, 2011.

J. Keane, S. Gershon, R. P. Wise, E. Mirabile-levens, J. Kasznica et al., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N Engl J Med, vol.345, pp.1098-104, 2001.

A. L. Smitten, T. A. Simon, M. C. Hochberg, and S. Suissa, A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis, Arthritis Res Ther, vol.10, p.45, 2008.

E. Baecklund, C. Sundström, A. Ekbom, A. I. Catrina, P. Biberfeld et al., Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma, Arthritis Rheum, vol.48, pp.1543-50, 2003.

M. Dougados, M. Soubrier, A. Antunez, P. Balint, A. Balsa et al., Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Ann Rheum Dis, vol.73, pp.62-70, 2014.

J. R. Hooyman, L. J. Melton, A. M. Nelson, W. M. O'fallon, and B. L. Riggs, Fractures after rheumatoid arthritis. A population-based study, Arthritis Rheum, vol.27, pp.1353-61, 1984.

S. Y. Kim, S. Schneeweiss, J. Liu, G. W. Daniel, C. Chang et al., Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis, Arthritis Res Ther, vol.12, issue.4, p.154, 2010.

T. P. Van-staa, P. Geusens, J. Bijlsma, H. Leufkens, and C. Cooper, Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, pp.3104-3116, 2006.

B. Seriolo, V. Ferretti, A. Sulli, E. Caratto, D. Fasciolo et al., Serum osteocalcin levels in premenopausal rheumatoid arthritis patients, Ann N Y Acad Sci, vol.966, pp.502-509, 2002.

E. M. Gravallese, C. Manning, A. Tsay, A. Naito, C. Pan et al., Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor, Arthritis Rheum, vol.43, pp.250-258, 2000.

Y. Shigeyama, T. Pap, P. Kunzler, B. R. Simmen, R. E. Gay et al., Expression of osteoclast differentiation factor in rheumatoid arthritis, Arthritis Rheum, vol.43, pp.2523-2553, 2000.

L. Yeo, K. Toellner, M. Salmon, A. Filer, C. D. Buckley et al., Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis, Ann Rheum Dis, vol.70, pp.2022-2030, 2011.

A. Gough, P. Sambrook, J. Devlin, A. Huissoon, C. Njeh et al., Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis, J Rheumatol, vol.25, pp.1282-1291, 1998.

R. J. Lories and F. P. Luyten, Osteoimmunology: Wnt antagonists: for better or worse?, Nat Rev Rheumatol, vol.5, pp.420-421, 2009.

D. Diarra, M. Stolina, K. Polzer, J. Zwerina, M. S. Ominsky et al., Dickkopf-1 is a master regulator of joint remodeling, Nat Med, vol.13, pp.156-63, 2007.

H. Appel, G. Ruiz-heiland, J. Listing, J. Zwerina, M. Herrmann et al., Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis, Arthritis Rheum, vol.60, pp.3257-62, 2009.

P. Garnero, N. Tabassi, and N. Voorzanger-rousselot, Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept, J Rheumatol, vol.35, pp.2313-2318, 2008.

L. Grondal, B. Tengstrand, B. Nordmark, P. Wretenberg, and A. Stark, The foot: still the most important reason for walking incapacity in rheumatoid arthritis: Distribution of symptomatic joints in 1,000 RA patients, Acta Orthopaedica, vol.79, pp.257-61, 2008.

E. S. Leib, E. M. Lewiecki, N. Binkley, and R. C. Hamdy, International Society for Clinical Densitometry. Official positions of the International Society for Clinical Densitometry, J Clin Densitom, vol.7, pp.1-6, 2004.

E. A. Hafez, H. E. Mansour, S. H. Hamza, S. G. Moftah, T. B. Younes et al., Bone mineral density changes in patients with recent-onset rheumatoid arthritis, Clin Med Insights Arthritis Musculoskelet Disord, vol.4, pp.87-94, 2011.

C. Kok and P. N. Sambrook, Secondary osteoporosis in patients with an osteoporotic fracture, Best Pract Res Clin Rheumatol, vol.23, pp.769-79, 2009.

K. Briot and C. Roux, Glucocorticoid-induced osteoporosis, RMD Open, vol.1, p.14, 2015.

K. Briot, B. Cortet, C. Roux, L. Fardet, V. Abitbol et al., 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, pp.493-501, 2014.

D. H. Solomon, S. S. Johnston, N. N. Boytsov, D. Mcmorrow, J. M. Lane et al., Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011, J Bone Miner Res, vol.29, pp.1929-1966, 2014.

A. A. Yusuf, T. J. Matlon, A. Grauer, R. Barron, D. Chandler et al., Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries, Arch Osteoporos, vol.11, p.31, 2016.

C. K. Cheng, H. Mcdonald-blumer, G. Boire, J. E. Pope, B. Haraoui et al., Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®), J Rheumatol, vol.37, pp.2221-2226, 2010.

E. Mckeown, V. P. Bykerk, D. Leon, F. Bonner, A. Thorne et al., Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort, Rheumatology (Oxford), vol.51, pp.1662-1671, 2012.

D. H. Solomon, J. N. Katz, J. P. Jacobs, L. Tourette, A. M. Coblyn et al., Management of glucocorticoidinduced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice, Arthritis Rheum, vol.46, pp.3136-3178, 2002.

S. W. Wade, S. Satram-hoang, and B. S. Stolshek, Long-term persistence and switching patterns among women using osteoporosis therapies: 24-and 36-month results from POSSIBLE US TM, Osteoporos Int, vol.25, pp.2279-90, 2014.

H. Kishimoto and M. Maehara, Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA, Arch Osteoporos, vol.10, p.231, 2015.

P. Hadji, L. Jacob, and K. Kostev, Gender-and age-related treatment compliance in patients with osteoporosis in Germany, Patient Prefer Adherence, vol.10, pp.2379-85, 2016.

M. Rousière, The importance of taking care of osteoporosis, Presse Med, vol.40, pp.900-909, 2011.

S. Alami, L. Hervouet, S. Poiraudeau, K. Briot, and C. Roux, Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views, PLoS ONE, p.11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01520976

F. Guillemin, A. Saraux, P. Guggenbuhl, C. H. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, vol.64, pp.1427-1457, 2001.

T. Sokka, B. Abelson, and P. T. , Mortality in rheumatoid arthritis: 2008 update, Clin Exp Rheumatol, vol.26, issue.5, pp.35-61, 2008.

A. Gough, P. Sambrook, J. Devlin, A. Huissoon, C. Njeh et al., Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis, J Rheumatol, vol.25, pp.1282-1291, 1998.

T. P. Van-staa, P. Geusens, J. Bijlsma, H. Leufkens, and C. Cooper, Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, pp.3104-3116, 2006.

D. Bliuc, N. D. Nguyen, V. E. Milch, T. V. Nguyen, J. A. Eisman et al., Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women, JAMA, vol.301, pp.513-534, 2009.

J. S. Smolen, F. C. Breedveld, G. R. Burmester, V. Bykerk, M. Dougados et al., Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force, Ann Rheum Dis, vol.75, pp.3-15, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01890959

M. A. Stoffer, M. M. Schoels, J. S. Smolen, D. Aletaha, F. C. Breedveld et al., Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update, Ann Rheum Dis, vol.75, pp.16-22, 2016.

M. Dougados, M. Soubrier, A. Antunez, P. Balint, A. Balsa et al., Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Ann Rheum Dis, vol.73, pp.62-70, 2014.

C. Roubille, V. Richer, T. Starnino, C. Mccourt, A. Mcfarlane et al., Evidencebased Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian DermatologyRheumatology Comorbidity Initiative, J Rheumatol, vol.42, pp.1767-80, 2015.

M. Dougados, M. Soubrier, E. Perrodeau, L. Gossec, F. Fayet et al., Impact of a nurse-led programme on comorbidity management and impact of a patient selfassessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA), Ann Rheum Dis, vol.74, pp.1725-1758, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01225510

C. K. Cheng, H. Mcdonald-blumer, G. Boire, J. E. Pope, B. Haraoui et al., Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®), J Rheumatol, vol.37, pp.2221-2226, 2010.

E. Mckeown, V. P. Bykerk, D. Leon, F. Bonner, A. Thorne et al., Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort, Rheumatology (Oxford), vol.51, pp.1662-1671, 2012.

D. H. Solomon, J. N. Katz, J. P. Jacobs, L. Tourette, A. M. Coblyn et al., Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice, Arthritis Rheum, vol.46, pp.3136-3178, 2002.

K. Briot, S. Paternotte, S. Kolta, R. Eastell, D. Felsenberg et al., FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study, PLoS One, vol.8, issue.12, 2013.

H. K. Genant, C. Y. Wu, C. Van-kuijk, and M. C. Nevitt, Vertebral fracture assessment using a semiquantitative technique, J Bone Miner Res, vol.8, pp.1137-1185, 1993.
DOI : 10.1002/jbmr.5650080915

T. Bartalena, M. F. Rinaldi, C. Modolon, L. Braccaioli, N. Sverzellati et al., Incidental vertebral compression fractures in imaging studies: Lessons not learned by radiologists, World J Radiol, vol.2, pp.399-404, 2010.
DOI : 10.4329/wjr.v2.i10.399

URL : https://doi.org/10.4329/wjr.v2.i10.399

L. Dirven, M. Van-den-broek, V. Groenendael, J. , D. Beus et al., Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis, BMC Musculoskelet Disord, vol.13, p.125, 2012.

W. Liu, S. Xu, X. Ma, L. Hu, L. Peng et al., Exploration of risk factors on the occurrence of osteoporotic vertebral fracture in patients with rheumatoid arthritis, Zhonghua Nei Ke Za Zhi, vol.53, pp.852-859, 2014.

A. El-maghraoui, A. Rezqi, A. Mounach, L. Achemlal, A. Bezza et al., Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment, Rheumatology (Oxford), vol.49, pp.1303-1313, 2010.

M. L. Rentero, E. Amigo, N. Chozas, F. Prada, M. Silva-fernández et al., Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy, BMC Musculoskeletal Disorders, vol.16, p.300, 2015.

A. Mohammad, D. Lohan, D. Bergin, S. Mooney, J. Newell et al., The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis, Rheumatology (Oxford), vol.53, pp.821-828, 2014.

F. Grados, J. Fechtenbaum, E. Flipon, S. Kolta, C. Roux et al., Radiographic methods for evaluating osteoporotic vertebral fractures, Joint Bone Spine, vol.76, pp.241-248, 2009.
DOI : 10.1016/j.jbspin.2008.07.017

A. Cranney, S. A. Jamal, J. F. Tsang, R. G. Josse, and W. D. Leslie, Low bone mineral density and fracture burden in postmenopausal women, CMAJ, vol.177, pp.575-80, 2007.

L. Langsetmo, D. Goltzman, C. S. Kovacs, J. D. Adachi, D. A. Hanley et al., Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD, J Bone Miner Res, vol.24, pp.1515-1537, 2009.
DOI : 10.1359/jbmr.090319

URL : http://onlinelibrary.wiley.com/doi/10.1359/jbmr.090319/pdf

C. Kok and P. N. Sambrook, Secondary osteoporosis in patients with an osteoporotic fracture, Best Pract Res Clin Rheumatol, vol.23, pp.769-79, 2009.
DOI : 10.1016/j.berh.2009.09.006

K. Ochi, E. Inoue, T. Furuya, K. Ikari, Y. Toyama et al., Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture, Osteoporos Int, vol.26, pp.961-969, 2015.

C. F. Buckens, D. Jong, P. A. Mol, C. Bakker, E. Stallman et al., Intra and interobserver reliability and agreement of semiquantitative vertebral fracture assessment on chest computed tomography, PLoS ONE, vol.8, p.71204, 2013.